Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b

Eva Mertens, Anna Kajaste-Rudnitski, Shessy Torres, Anneke Funk, Marie Pascale Frenkiel, Isabelle Iteman, Alexander A. Khromykh, Philippe Desprès

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The interferon-inducible 2′,5′-oligoadenylate synthetase 1b (Oas1b) protein inhibits West Nile virus (WNV) infection by preventing viral RNA (vRNA) accumulation in infected cells. Serial passage of WNV in Oas1b-expressing mouse cells selected a virus variant with improved growth capacity. Two major amino acid substitutions were identified in this Oas1b-resistant WNV variant: NS3-S365G in the ATPase/helicase domain of NS3 and 2K-V9M in the C-terminal segment of NS4A. To assess their effect on antiviral activity of Oas1b, the NS3 and 2K mutations were engineered into an infectious WNV cDNA clone. The NS3 mutation alters requirement of ATP for ATPase activity and attenuates Oas1b-mediated suppression of vRNA accumulation. However, growth of NS3-mutant virus remains impaired in Oas1b-expressing cells. Only the 2K-V9M mutation efficiently rescued viral growth by promoting vRNA replication. Thus, WNV resistance to Oas1b antiviral action could be attributed to the 2K-V9M substitution with a potential role of NS3-S365G through rescue of vRNA accumulation.

Original languageEnglish
Pages (from-to)176-185
Number of pages10
JournalVirology
Volume399
Issue number1
DOIs
Publication statusPublished - Mar 30 2010

Fingerprint

West Nile virus
Ligases
Antiviral Agents
Viral RNA
Peptides
Mutation
Adenosine Triphosphatases
Growth
Viruses
Serial Passage
Virus Diseases
Amino Acid Substitution
2',5'-oligoadenylate
Interferons
Complementary DNA
Clone Cells
Adenosine Triphosphate

Keywords

  • 2′,5′-oligoadenylate synthetases
  • Flavivirus 2K peptide
  • Flavivirus NS3 helicase
  • Innate immunity
  • Viral evasion
  • West Nile virus

ASJC Scopus subject areas

  • Virology

Cite this

Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b. / Mertens, Eva; Kajaste-Rudnitski, Anna; Torres, Shessy; Funk, Anneke; Frenkiel, Marie Pascale; Iteman, Isabelle; Khromykh, Alexander A.; Desprès, Philippe.

In: Virology, Vol. 399, No. 1, 30.03.2010, p. 176-185.

Research output: Contribution to journalArticle

Mertens, Eva ; Kajaste-Rudnitski, Anna ; Torres, Shessy ; Funk, Anneke ; Frenkiel, Marie Pascale ; Iteman, Isabelle ; Khromykh, Alexander A. ; Desprès, Philippe. / Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b. In: Virology. 2010 ; Vol. 399, No. 1. pp. 176-185.
@article{8a8d175aa79b47bea0365938e7d23912,
title = "Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b",
abstract = "The interferon-inducible 2′,5′-oligoadenylate synthetase 1b (Oas1b) protein inhibits West Nile virus (WNV) infection by preventing viral RNA (vRNA) accumulation in infected cells. Serial passage of WNV in Oas1b-expressing mouse cells selected a virus variant with improved growth capacity. Two major amino acid substitutions were identified in this Oas1b-resistant WNV variant: NS3-S365G in the ATPase/helicase domain of NS3 and 2K-V9M in the C-terminal segment of NS4A. To assess their effect on antiviral activity of Oas1b, the NS3 and 2K mutations were engineered into an infectious WNV cDNA clone. The NS3 mutation alters requirement of ATP for ATPase activity and attenuates Oas1b-mediated suppression of vRNA accumulation. However, growth of NS3-mutant virus remains impaired in Oas1b-expressing cells. Only the 2K-V9M mutation efficiently rescued viral growth by promoting vRNA replication. Thus, WNV resistance to Oas1b antiviral action could be attributed to the 2K-V9M substitution with a potential role of NS3-S365G through rescue of vRNA accumulation.",
keywords = "2′,5′-oligoadenylate synthetases, Flavivirus 2K peptide, Flavivirus NS3 helicase, Innate immunity, Viral evasion, West Nile virus",
author = "Eva Mertens and Anna Kajaste-Rudnitski and Shessy Torres and Anneke Funk and Frenkiel, {Marie Pascale} and Isabelle Iteman and Khromykh, {Alexander A.} and Philippe Despr{\`e}s",
year = "2010",
month = "3",
day = "30",
doi = "10.1016/j.virol.2009.12.036",
language = "English",
volume = "399",
pages = "176--185",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b

AU - Mertens, Eva

AU - Kajaste-Rudnitski, Anna

AU - Torres, Shessy

AU - Funk, Anneke

AU - Frenkiel, Marie Pascale

AU - Iteman, Isabelle

AU - Khromykh, Alexander A.

AU - Desprès, Philippe

PY - 2010/3/30

Y1 - 2010/3/30

N2 - The interferon-inducible 2′,5′-oligoadenylate synthetase 1b (Oas1b) protein inhibits West Nile virus (WNV) infection by preventing viral RNA (vRNA) accumulation in infected cells. Serial passage of WNV in Oas1b-expressing mouse cells selected a virus variant with improved growth capacity. Two major amino acid substitutions were identified in this Oas1b-resistant WNV variant: NS3-S365G in the ATPase/helicase domain of NS3 and 2K-V9M in the C-terminal segment of NS4A. To assess their effect on antiviral activity of Oas1b, the NS3 and 2K mutations were engineered into an infectious WNV cDNA clone. The NS3 mutation alters requirement of ATP for ATPase activity and attenuates Oas1b-mediated suppression of vRNA accumulation. However, growth of NS3-mutant virus remains impaired in Oas1b-expressing cells. Only the 2K-V9M mutation efficiently rescued viral growth by promoting vRNA replication. Thus, WNV resistance to Oas1b antiviral action could be attributed to the 2K-V9M substitution with a potential role of NS3-S365G through rescue of vRNA accumulation.

AB - The interferon-inducible 2′,5′-oligoadenylate synthetase 1b (Oas1b) protein inhibits West Nile virus (WNV) infection by preventing viral RNA (vRNA) accumulation in infected cells. Serial passage of WNV in Oas1b-expressing mouse cells selected a virus variant with improved growth capacity. Two major amino acid substitutions were identified in this Oas1b-resistant WNV variant: NS3-S365G in the ATPase/helicase domain of NS3 and 2K-V9M in the C-terminal segment of NS4A. To assess their effect on antiviral activity of Oas1b, the NS3 and 2K mutations were engineered into an infectious WNV cDNA clone. The NS3 mutation alters requirement of ATP for ATPase activity and attenuates Oas1b-mediated suppression of vRNA accumulation. However, growth of NS3-mutant virus remains impaired in Oas1b-expressing cells. Only the 2K-V9M mutation efficiently rescued viral growth by promoting vRNA replication. Thus, WNV resistance to Oas1b antiviral action could be attributed to the 2K-V9M substitution with a potential role of NS3-S365G through rescue of vRNA accumulation.

KW - 2′,5′-oligoadenylate synthetases

KW - Flavivirus 2K peptide

KW - Flavivirus NS3 helicase

KW - Innate immunity

KW - Viral evasion

KW - West Nile virus

UR - http://www.scopus.com/inward/record.url?scp=77249129709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249129709&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2009.12.036

DO - 10.1016/j.virol.2009.12.036

M3 - Article

C2 - 20100623

AN - SCOPUS:77249129709

VL - 399

SP - 176

EP - 185

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -